SELECT FROM MENU

Therapy Areas
Drug Classes

       Therapy Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Advanced NSCLC

Advanced NSCLC

SCLC

SCLC

Biomarkers

Biomarkers

       Drug Classes

Targeted Therapies

Targeted Therapies

Immunotherapies

Immunotherapies

ADCs

ADCs

Tom John

Tom John

Peter MacCallum Cancer Centre, Melbourne

Associate Prof. Tom John is a thoracic medical oncologist and Deputy Director of Medical Oncology at the Peter MacCallum Cancer Centre in Melbourne, Australia. He has led and contributed to practice-changing trials in EGFR-mutant non-small cell lung cancer, including the AURA, FLAURA and ADAURA osimertinib programmes and circulating tumour DNA / molecular residual disease research, alongside translational work in mesothelioma. He is an Associate Editor of the Journal of Thoracic Oncology, serves on the ESMO lung tumour faculty, chairs the Scientific Committee of the Thoracic Oncology Group of Australasia, and is a frequent speaker at major international congresses.

Connect

Tom John

Featured in